Abstract Study subjects (6 women and 5 men) over the age of 40 years with fasting low-density lipoprotein cholesterol concentrations >130 mg/dL were studied during three 5-week diet phases and one 10-week phase: baseline (36% fat: 13% saturated fatty acids [SFA], 12% monounsarurated fatty acids [MUFA], 8% polyunsaturated fatty acids [PUFA], and 128 mg cholesterol/1000 kcal); reduced fat (29% fat: 7% SFA 9% MUFA 11% PUFA and 85 mg cholesterol/1000 kcal); and two low fat (15% fat: 5% SFA 5% MUFA 3% PUFA and 73 mg cholesterol/1000 kcal). Body weight was maintained during the first three 5-week phases (baseline, reduced fat, and low fat [-• energy]) and decreased during the last 10-week phase when the low-fat diet was provided such that the subjects determined, in part, their caloric intake (low fat [I energy]). Mean body weight declined by 0.62±0.47 kg/wk during the first 5 weeks and 0.43±0.43 kg/wk during the second 5 weeks of the 10-week low-fat (I energy) period. Relative to the baseline diet, plasma cholesterol concentrations decreased from 226±33 to 195 + 19 (-13%), 208±22 (-7%), and 190±19 (-15%) mg/dL when the subjects consumed the reduced-fat, low-fat (-» energy), and low-fat (j energy) diets, respectively. Low-density lipoprotein cholesterol concentrations decreased T here is general agreement that the fat content of the average diet should be reduced. 1 Reference to such recommendations is not without historical basis.
T here is general agreement that the fat content of the average diet should be reduced. 1 Reference to such recommendations is not without historical basis. 2 Additionally, the general consensus appears to be that cutting the saturated fat content of the diet imparts the most benefit with respect to lowering plasma cholesterol levels. 35 The optimal level to which the total and saturated fat content in the diet should be reduced is far more controversial. 610 Current National Cholesterol Education Program (NCEP) dietary recommendations concerning fat are relatively broad: total fat intake s30% and saturated fat intake £10% of calories (step 1) or <.!% (step 2) of calories, depending on initial plasma lipid levels and initial response.
1 Expected reductions in plasma lipid concentrations include declines in both low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) levels. 31115 The advocates of a moderate approach to dietary management, ie, maintaining the total fat content of the diet at or about 30% of calories, cite concern over the lowering of HDL-C concentrations and theoretical increased risk of cardiovascular disease. 8 - 9 Other workers have suggested that diet-induced decreases in HDL concentrations should not be interpreted equivalentry to low HDL concentrations independent of diet. 16 Although diets relatively high in monounsaturated fatty acids (MUFA) have been suggested as selectively lowering LDL-C without altering HDL-C concentrations, confirmation of this observation when the total fat content of the diet is within the recommended guidelines has been inconsistent.
would make complying with a low-fat diet more difficult unless specially modified products were consumed. Therefore, most recommendations advocate replacing fat with complex carbohydrate.
1 - 34 Potential benefits to this approach include increased nutrient density and fiber content in the diet 35 - 36 and possibly satiety or a feeling of fullness depending on the source of supplemental carbohydrate. 37 - 38 Disadvantages include, at least transiently, an increase in plasma triglyceride concentrations and a concomitant decrease in HDL-C concentrations.
3 -4 -39 - 43 An increase in plasma triglyceride concentration can be avoided by small incremental increases as opposed to one big increase in the carbohydrate content of the diet. 44 The third alternative when reducing the fat content of the diet is to not replace it with anything. The approach of radically reducing the fat content of the diet without specific efforts to maintain body weight has been reported to result in a spontaneous decrease in caloric intake and weight loss 745 - 46 and, when assessed, a dramatic lowering of plasma lipid concentrations and reduction in the severity of coronary atherosclerotic lesions. 6 ' 7 ' 47 '
48
Taking the above points into consideration, a study was designed to investigate the effects of consuming a diet containing 36% of calories as fat with a fatty acid composition approximating that currently consumed in the United States, a reduced-fat diet containing 29% of calories as fat designed to met NCEP step 2 guidelines (reduced fat), and a low-fat diet containing 15% of calories as fat (low fat). The latter diet was consumed either at levels to maintain body weight (as were the baseline and reduced-fat diets) or at levels determined, in part, by the individual volunteer. The study volunteers were middle-aged and older men and women with moderately elevated plasma lipid levels and mean body mass indexes. The results of the study suggest that drastically reducing the fat content of the diet had an unfavorable effect on plasma lipoprotein concentrations unless accompanied by weight loss. Additionally, maximal effects of dietary modification on plasma lipoprotein concentrations were realized only during the initial weight-loss period.
Methods

Subjects
Eleven (6 female and 5 male) subjects with a mean age of 60 years (range, 44 to 78 years) with LDL-C concentrations greater than 130 mg/dL underwent a medical history, physical examination, and had clinical chemical analyses performed before enrollment in the study. The subjects had no evidence of any chronic illness, including hepatic, renal, thyroid, or cardiac dysfunction. They did not smoke, indicated they were able to abstain from alcohol for the duration of the study period, and were not taking medication known to affect plasma lipid levels (eg, lipid-lowering drugs, /3-adrenergic blocking agents, diuretics, or hormones). All the women were postmenopausal. These subjects were recruited as part of a larger study to investigate the effects of fatty acid and cholesterol intake on plasma lipid concentrations.
14 -49 - 51 The initial study cohort was composed of 15 subjects, 4 of whom chose not to participate in the later additional phases of the study. Eliminating their screening data from the remaining subjects' data did not significantly change the overall characteristics of the study group. This protocol has been approved by the Human Investigation Review Committee of the New England Medical Center and Tufts University.
Experimental Design
All subjects participated in each of three 5-week study phases. They first consumed a diet similar in fat content to that currently consumed in the United States (baseline), which provided 17% of calories as protein, 48% as carbohydrate, 36% as fat (13% saturated fatty acids [SFA], 12% MUFA, 8% polyunsaturated fatty acids [PUFA]), and 128 mg cholesterol/ 1000 kcal. The subjects next consumed a reduced-fat diet (reduced fat) containing 17% of calories as protein, 53% as carbohydrate, 29% as fat (7% SFA, 9% MUFA, 11% PUFA), and 85 mg cholesterol/1000 kcal. During the third 5-week period, the subjects ate a low-fat (-» energy) diet containing 17% protein, 68% carbohydrate, 15% fat (5% SFA, 5% MUFA, 3% PUFA), and 73 mg cholesterol/1000 kcal. Each diet was consumed for 5 weeks at caloric levels that maintained stable body weights. Plasma lipid levels stabilize after 4 weeks on a diet, 52 and there is no effect of order of diets on study outcome. 51 Mean caloric intake was 2679±608 kcal (range, 2000 to 4000 kcal) during the first three phases.
The fourth phase of the study (low fat [| energy]) was designed to provide the same nutrient composition as the low-fat (third) phase, but it allowed the subjects to determine, in part, their caloric intake. This final diet was conceived to test the hypothesis that drastically reducing the fat content of the diet will result in spontaneous weight loss and subsequently beneficially affect plasma lipid profiles. To accomplish this aim within the context of a metabolic study protocol, subjects were provided with and required to consume two thirds of the caloric intake they received during the low-fat (-» energy) phase. All food components of the diet were reduced proportionally. Participants were also provided with an additional two thirds of their caloric intake in the form of 200-kcal portions of frozen entrees normally present in their diet, the composition of which was similar to that of the low-fat diet. The subjects were instructed that they had to consume the first two thirds of the food provided and could determine how much additional food they were to consume thereafter. In the most extreme cases they could have either consumed one third fewer or one third more calories than on the low-fat (-• energy) phase. When a subject reported that a food item was consumed subsequent to the previous visit (s3 days), it was replaced so that the additional food was always available. The study period for the fourth (low-fat [| energy]) phase was thus continued for an additional 5 weeks (10 weeks total) so that potential effects of changes in body weight on plasma lipid concentration could be better monitored. Data are reported for the first 5-week time point for comparisons with the other dietary phases and for the second 5-week time point for comparisons within that phase.
Triplicate preparations of each complete meal cycle (3 days) for each diet phase were analyzed by Hazleton Laboratories America, Inc. The composition, fatty acid profile, and cholesterol content of the diets are shown in Table 1 . In general, there was good agreement between the analytical and calculated data except for cholesterol, which was overestimated in the food composition tables.
All food and drink were provided by the Metabolic Research Unit of the US Department of Agriculture (USDA) Human Nutrition Research Center on Aging at Tufts University for consumption on site or packaged for takeout. The subjects were required to report to the research unit a minimum of three times per week, have blood pressure and weight measured at each visit, and consume at least one meal on site each time. They were encouraged to maintain their habitual level of physical activity throughout the study period. Four times during the final week of study phases one through three or during weeks 5 and 10 of the low-fat (| energy) phase fasting blood samples were obtained for lipid and apolipopro- tein determinations. On one day during the final week of the first three phases or during weeks 5 and 10 of the low-fat (J, energy) phase subjects consumed their three meals plus one snack at standardized intervals, and blood was sampled at 0, 5, 8, 10, and 24 hours.
Biochemical Analysis
Fasting (12-hour) blood was collected in tubes containing 0.1% EDTA, and very-low-density lipoprotein (VLDL) was isolated from plasma by a single ultracentrifugational spin at density 1.006 g/mL (39 000 rpm for 18 hours at 4°C). Plasma and the 1.006-g/mL infranate were assayed for total cholesterol and/or triglyceride with an Abbott Diagnostics ABA-200 bichromatic analyzer using enzymatic reagents. 33 HDL-C was measured as described, 54 and non-HDL-C (total cholesterol minus HDL-C) was determined in nonfasting plasma after HDL-C precipitation. Lipid assays were standardized through the Lipid Standardization Program of the Centers for Disease Control and Prevention, Atlanta, Ga. Within-run and between-run coefficients of variation of these assays were less than 5%.
Apolipoprotein (apo) B was assayed with a noncompetitive, enzyme-linked assay by using immunopurified polyclonal antibodies 53 in plasma after VLDL had been removed. Plasma apoA-I was assayed in the same manner by using apoA-I polyclonal antibodies. 56 Coefficients of variation for both assays were less than 5% within runs and less than 10% between runs. Assays were standardized with LDL containing only apoB and purified apoA-I with the protein content determined by amino add analysis. Lipoprotein(a) [Lp(a)] was quantified by using an enzyme-linked assay with a monoclonal antibody that did not cross-react with plasminogen as the first antibody and a polyclonal antibody as the second antibody that was directed against the apo(a) portion of the Lp(a) particle (Terumo Medical Corp). Lp(a) concentrations are expressed as total Lp(a) mass in milligrams per deciliter. 
Statistical Analysis
The data were analyzed by using SAS (STATISTICAL ANALYSIS SYSTEM; SAS Institute Inc) both for the IBM-compatible personal computer using version 6.04 and as run on a VAX mainframe (Digital Equipment Corp), PROC GLM was used for ANOVA procedures for repeated measures followed by Tukey's t test performed at the ^=.05, .01, and .001 levels of comparison.
Results
The mean age of the study subjects was 60 ±13 years (Table 2) ; all subjects had somewhat elevated body mass indexes. At the time of screening they had a mean LDL-C concentration of 169±22 mg/dL. The women tended to have higher HDL-C and lower LDL-C concentrations than the men.
The consumption of the reduced-fat diet (29% of calories as fat) resulted in 13%, 18%, and 10% decreases in total cholesterol, LDL-C, and HDL-C concentrations, respectively, relative to the baseline diet (36% of calories as fat) (Table 3 and Fig 1) . Changes in LDL apoB concentrations mirrored those of LDL-C. In contrast, despite a decrease in HDL-C concentrations, there was little change in the concentration of apoA-I. These changes resulted in similar total cholesterol/ HDL-C ratios but significantly lower LDL apoB/apoA-I ratios. No significant effects of consuming the reducedfat diet on the concentrations of triglyceride and Lp(a) relative to the baseline diet were observed.
When the fat content of the diet was decreased to 15% of calories and consumed at isocaloric levels (low fat [-> energy]), there was a less favorable effect on plasma lipid levels than when the fat content of the diet was reduced to only 29% of calories. Relative to the baseline diet, there were 7%, 14%, and 25% decreases in total cholesterol, LDL-C, and HDL-C concentrations during the low-fat (-» energy) period (Table 3 and Fig  1) . These changes were accompanied by dramatic increases in VLDL cholesterol (95%) and triglyceride (75%) concentrations.
Relative to the baseline diet the decrease in LDL apoB concentrations (-17%) was similar to that observed for LDL-C concentrations (-14%); however, as Values without a common symbol were significantly different at P<.05 using Tukey's f test. §Raw data were transformed to k>g 10 values before statistical analysis. Values are mean±SD.
we observed during consumption of the reduced-fat diet, the decrease in apoA-I levels (-10%) was attenuated relative to the decrease in HDL-C concentrations (-25%). The total cholesterol/HDL-C ratio was significantly higher during consumption of the low-fat (-> energy) diet, whereas the LDL apoB/apoA-I ratio was intermediate between the previous two phases. Similar to during the reduced-fat diet phase, Lp(a) concentrations were not significantly affected during the period when the subjects consumed the low-fat (-» energy) diet.
As intended by the study design, there was little change in body weight during the reduced-fat and low-fat (-• energy) periods (-0.06±0.27 and -0.14±0.20 kg/wk, respectively). Allowing the subjects to adjust their caloric intake during the low-fat (| energy) diet resulted in a significant weight loss. On average, the subjects reduced their caloric intake to a level that resulted in an average weight loss of 0.62 ±0.47 kg/wk during the first 5-week phase of the low-fat (I energy) diet period. This result confirmed the anecdotal comments made by the study subjects that suggested that the amount of food provided during the low-fat (-» energy) diet phase that was necessary to maintain body weight was more than they were comfortable consuming and that subjective feelings of hunger were satisfied with a lower caloric intake. The effects of consuming the low-fat (j energy) diet and weight loss on plasma lipid concentrations were striking.
At the end of the first 5 weeks of the low-fat (| energy) diet there was a 15% decrease in total cholesterol, a 23% decrease in LDL-C, and an 18% decrease in HDL-C concentrations relative to baseline (Table 3 and Fig 1) . These decreases in cholesterol concentrations, with the exception of HDL-C, were significantly greater than those observed for any of the other diet phases. Plasma triglyceride concentrations at the end of the first 5 weeks of the low-fat (j energy) diet were not significantly different from levels observed at the end of the baseline and reduced-fat periods. VLDL cholesterol concentrations remained somewhat elevated above baseline levels.
During the first 5 weeks of the low-fat (| energy) diet LDL apoB concentrations were reduced to a similar extent as that observed for LDL-C concentrations. Declines in apoA-I concentrations (-12%) were again less dramatic than that observed for HDL-C concentrations (-18%). The ratio of total cholesterol/HDL-C was similar to the same ratio at the end of the baseline period. In contrast, the ratio of LDL apoB/apoA-I during the first 5 weeks of the low-fat (J, energy) diet was somewhat lower than that observed during the baseline period and similar to that observed during the low-fat (-» energy) period.
Plasma lipid concentrations were monitored in the postprandial state, when subjects consumed their three meals plus one snack at standardized intervals (Table 4 and Fig 2) . Postprandial plasma cholesterol and non-HDL-C concentrations were not significantly different from fasting values. In contrast, HDL-C concentrations consistently exhibited a postprandial fall of 5% to 7%, which was significantly different from fasting levels over all the diet phases. Mean postprandial plasma triglyceride concentrations (at 5-, 8-, and 10-hour time points) were approximately twofold higher than fasting values and were statistically different from fasting values for all diet phases. By 24 hours plasma triglyceride concentrations were statistically indistinguishable from the initial fasting values regardless of dietary treatment.
The differences observed among diets with respect to postprandial total cholesterol, non-HDL-C, HDL-C, and triglyceride concentrations were similar to those observed in the fasting state. Postprandial total cholesterol concentrations were from lowest to highest when the subjects consumed the low-fat (j, energy), reducedfat, low-fat (-» energy), and baseline diets. In general, non-HDL-C concentrations were lowest when the subjects consumed the low-fat (| energy) and reduced-fat diets and highest when they consumed the low-fat (-> energy) and baseline diets. HDL-C concentrations were from lowest to highest when the subjects consumed the low-fat (-» energy), low-fat (j energy), reduced fat, and baseline diets. Postprandial triglyceride concentrations were significantly higher at the end of the low-fat (-» energy) diet than at the end of any of the other diet periods.
The study subjects continued to consume the low-fat (| energy) diet for an additional 5 weeks (Table 5) . Although there was a persistent loss of body weight, albeit at a somewhat slower rate (0.62±0.47 versus 0.43±0.43 per week, first and second diet periods, respectively), the greatest effect of weight loss on plasma lipid and apolipoprotein concentrations occurred after the first 5 weeks of the fourth study period. Plasma lipid and apolipoprotein concentrations remained remarkably stable during the second 5-week period of the low-fat (J. energy) phase.
Discussion
Impressive observations have been made with respect to the benefits of extremely low-fat diets on plasma lipid concentrations and regression of atherosclerotic plaque. 6 ' 7 ' 58 Populations that normally consume low-fat diets are generally reported to have lower plasma lipid concentrations and rates of coronary heart disease than those consuming higher fat diets. 59 In such populations caloric intake tends to be lower and fiber intake higher than in societies consuming higher fat diets, and obesity is generally not cited as a major public health problem. 5961 In general, the consumption of ad libitum quantities of low-fat diets relative to higher fat diets on an experimental basis is accompanied by weight loss. 45 ' 46 -6268 Increasing the fat intake of people who habitually consume a low-fat diet has been reported to result in weight gain and adverse effects on plasma lipid concentrations. 69 The results of a recent metaanarysis of studies assessing the relation between weight change and plasma lipid levels concluded that weight loss is associated with an improvement of plasma lipid profiles. 70 Taking these observations into consideration, we investigated the effects of reduced-fat and low-fat diets with and without weight loss on plasma lipid, lipoprotein, and apolipoprotein concentrations. Middle-aged and elderly female and male subjects with plasma LDL-C concentrations that indicated the need for dietary modification were targeted, since this is the group for which recommendations to reduce dietary fat content are frequently made. (Although body mass index was not a screening criterion, the group of subjects participating in the study, qualifying on the basis of having LDL-C levels above 130 mg/dL, had a somewhat elevated mean body mass index [27.0±4.5]). We do not have anthropometric measures of the study subjects, and differences in body fat distribution could have modified the effect of weight loss on their plasma lipid levels. Given that limitation, the results of the investigation suggest, relative to a baseline diet, that when body weight was maintained, reducing the total and saturated fat content of the diet in accordance with the current NCEP step 2 guidelines resulted in a significant decrease in total cholesterol, LDL-C, and HDL-C concentrations. Further reducing the total fat content of the diet under the same conditions also resulted in decreased concentrations of total cholesterol, LDL-C, and HDL-C, although the reductions in total cholesterol and LDL-C were less dramatic and the decrease in HDL-C greater than when the subjects consumed the reduced-fat diet. Accompanying these changes was a striking increase in plasma triglycerides and VLDL cholesterol concentrations. The end result was a less favorable plasma lipid profile with respect to cardiovascular risk. Allowing the subjects to decrease their caloric intake while maintaining the macronutri- ANOVA for each time point using data from all four diet groups showed a significant effect of diet (P<.05) for each variable at each time point. At each sampling time, mean values without a common symbol are significantly different using Tukey's f test at P<05.
A three-way ANOVA with main effects of diet, time, and subject showed that time was a significant variable for HDL-C and triglycerides only. Of potential concern was the consistent decrease in HDL-C concentrations, presumably resulting from the decrease in saturated fat intake. This observation is not without precedent. 3 ' 1115 In the current study this trend was most pronounced during the period when the subjects consumed the low-fat (-» energy) diet, but it was observed at the end of the other dietary phases as well. Significantly, in all cases apoA-I levels did not decline at the same rate as HDL-C levels. This observation suggests that the number of HDL particles in the circulation was maintained.
In contrast to changes in HDL-C and apo A-I levels, LDL-C and LDL apoB concentrations tended to change in a parallel manner regardless of the dietary perturbation. These data suggest that the number of particles but not the size of the particles was affected by dietary modification of the magnitude induced in the current studies. Additionally, when either the reduced- 
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fat or low-fat (| energy) diets were consumed, the relative change in LDL and LDL apoB concentrations exceeded that of HDL-C or apoA-I. When the subjects consumed the reduced-fat diet, which was consistent with NCEP step 2 guidelines, total cholesterol, LDL-C, and HDL-C concentrations decreased relative to the baseline diet. Further reducing the fat content of the diet from 29% to 15% of calories was achieved by eliminating most sources of added fat. In keeping with the design of the study the actual foods making up the diet were not altered. This resulted in a large decrease in poryunsaturated fat, a moderate decrease in monounsaturated fat, and a smaller decrease in saturated fat in the diet. These changes themselves may have accounted for the greater decrease in HDL-C than LDL-C when subjects consumed the low-fat ( -> energy) diet. However, at extremely low levels of total fat in the diet, observations pertaining to the differential effects of the different individuals or classes of fatty acids may not be valid.
Decreasing the fat content of the diet and increasing the carbohydrate content likely resulted in a concomitant increase in the level of fiber in the diet, 35 -36 a variable that was not specifically addressed in the current study. Independent effects of total and soluble fiber on plasma lipid levels have been documented. 7173 However, the primary aim of the present investigation was to assess the effects of varying the fat content of the diet with commonly available foods. An alternate approach, to isolate the independent effects of fat and fiber, would have necessitated artificially keeping the fiber constant while altering the fat content of the diet, which would have answered a different but interesting experimental question.
The trigfyceride levels remained relatively stable when the carbohydrate content of the diet was increased by 5% of calories to compensate for the decrease in the fat content of the diet. When the carbohydrate content of the diet was further increased by 15% there was a dramatic increase in plasma triglyceride levels, perhaps secondary to an increase in insulin levels induced by the increased carbohydrate content. We cannot answer the question of whether these levels would have decreased had the subjects consumed the diet for longer periods of time. Additionally, we cannot address the issue of what effect increasing the fiber content of the diet may have on plasma lipid levels. But we did observe that when the subjects consumed the low-fat (j. energy) diet the increase in plasma triglyceride levels was attenuated to the point of not being significantly different from either the baseline or reduced-fat diet phases. This observation was most striking when the postprandial plasma triglyceride levels were examined. In general, maximal concentrations of plasma triglycerides were observed in all diet phases at the 8-and 10-hour time points of the study and were lowest when the subjects consumed the low-fat (| energy) diet. These data suggest that the dramatic increase in plasma triglyceride concentrations observed after consumption of the low-fat (-» energy) diet when assessed in the fasting state is far less than when monitored in the postprandial state.
The baseline, reduced-fat, and low-fat (-» energy) phases each lasted for 5 weeks. This time period is adequate to achieve stable plasma lipid levels when body weight remains constant. 52 During the 10-week low-fat (i energy) phase, plasma lipid concentrations appeared to reach stable levels by the fifth week. However, this apparent plateau in the lipid levels was maintained despite the continued trend of the study subjects to decrease their body weight throughout the entire period. Whether continuing the study would have resulted in continued alterations in plasma lipid con- VLDL Indicates very-low-density lipoproteln; LDL-C, low-density lipoproteln cholesterol; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; apo, apollpoproteln; and Lp(a), lipoprotein(a). Values are mean±SD and are expressed in milligrams per deciliter (mean percent difference from baseline). See "Methods" for definitions of diets.
*Raw data were transformed to log t0 values before statistical analysis.
centrations clearly needs to be investigated. In addition, at what level plasma lipids stabilize once lower body weights are achieved and maintained remains to be determined.
Consuming a low-fat diet in the absence of specific efforts to maintain a constant body weight resulted in weight loss. No apparent relation between the magnitude of body weight change and change in plasma lipid concentrations was identified. A larger sample size would have been necessary to more thoroughly assess such issues.
The present study was designed to study the effect of moderate and radical reductions in fat intake on plasma measures of cardiovascular risk. The data suggest, at least in the short term, that diets consistent with NCEP step 2 guidelines result in significant reductions in plasma lipid concentrations; however, radical reductions in fat intake have a beneficial effect on plasma lipid profiles only when accompanied by weight loss.
